Complementarity between Public and Commercial Databases of Bioactive Compounds

presentation · 10 years ago
by Sorel Muresan (AstraZeneca)

Since 2004 public cheminformatic databases and their collective functionality for exploring relationships between compounds, protein sequences, literature and assay data have advanced dramatically. In parallel, commercial sources that extract and curate such relationships from journals and patents have also been expanding.

This work updates a previous comparative study [Southan, C.; Varkonyi, P.; Muresan, S. Current Topics in Medicinal Chemistry 2007, 7, 1502] of databases chosen because of their bioactive content, availability of downloads and facility to select informative subsets.